Short answer
Adicet Bio Inc (ACET) filed an 8-K current report with the SEC on November 13, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Director Andrew Sinclair resigned November 13, 2026 from the Board, Audit Committee and NCG Committee.
Adicet Bio Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Director Andrew Sinclair resigned November 13, 2026 from the Board, Audit Committee and NCG Committee
- Board size reduced from seven to six, with no reported disagreement driving Sinclair’s departure
- Michael Grissinger appointed to the Audit Committee, preserving an independent audit committee member
- Grissinger named NCG Committee chairperson, strengthening board governance continuity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Adicet Bio Inc 8-K filings
Get the next ACET 8-K as it lands
Follow ACET for push alerts, or ask the research agent what this filing means.